Page last updated: 2024-11-04

linsidomine and Experimental Mammary Neoplasms

linsidomine has been researched along with Experimental Mammary Neoplasms in 2 studies

linsidomine: RN given refers to parent cpd; structure

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drapier, JC1
Hirling, H1
Wietzerbin, J1
Kaldy, P1
Kühn, LC1
Lepoivre, M1
Fieschi, F1
Coves, J1
Thelander, L1
Fontecave, M1

Other Studies

2 other studies available for linsidomine and Experimental Mammary Neoplasms

ArticleYear
Biosynthesis of nitric oxide activates iron regulatory factor in macrophages.
    The EMBO journal, 1993, Volume: 12, Issue:9

    Topics: Aconitate Hydratase; Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Cell Line; Cells

1993
Inactivation of ribonucleotide reductase by nitric oxide.
    Biochemical and biophysical research communications, 1991, Aug-30, Volume: 179, Issue:1

    Topics: Animals; Cell Line; Cytosol; Electron Spin Resonance Spectroscopy; Glutathione; Kinetics; Mammary Ne

1991